June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
The Comparison of Podoplanin Expression Between Choroidal and Conjunctival Melanoma
Author Affiliations & Notes
  • Kazuichi Maruyama
    Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan
  • Yoshihiko Usui
    Ophthalmology, Tokyo Medical University, Tokyo, Japan
  • Shunichiro Ueda
    Ophthalmology, Tokyo Medical University, Tokyo, Japan
  • Yuko Maruyama
    Ophthalmology, Kyoto Prefectural Univ of Med, Kyoto, Japan
  • Hiroshi Goto
    Ophthalmology, Tokyo Medical University, Tokyo, Japan
  • Toru Nakazawa
    Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan
  • Footnotes
    Commercial Relationships Kazuichi Maruyama, None; Yoshihiko Usui, None; Shunichiro Ueda, None; Yuko Maruyama, None; Hiroshi Goto, None; Toru Nakazawa, Kowa Company Ltd. (F), Kowa Company Ltd. (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3670. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kazuichi Maruyama, Yoshihiko Usui, Shunichiro Ueda, Yuko Maruyama, Hiroshi Goto, Toru Nakazawa; The Comparison of Podoplanin Expression Between Choroidal and Conjunctival Melanoma. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3670.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Ocular melanoma is the most common primary eye tumor observed in adults. It has been reported that conjunctival or ciliary body melanoma are associated with lymphatic metastasis due to the induction of lymphangiogenesis. However, the formation of lymphatic vessels in choroidal melanoma is a subject that has not well investigated. The purpose of this present study was to investigate if the discriminative expression of podoplanin (D2-40) is confirmed in choroidal melanoma in comparison to conjunctival melanoma.

Methods: This study involved 22 patients (13 males and 9 females) with conjunctival melanoma (12 cases) or choroidal melanoma (10 cases). To visualize the podoplanin or macrophage, anti-podoplanin (D2-40) or anti-CD68 antibody was used. The area covered by a podoplanin-positive structure or CD68-positive cells was determined using National Institutes of Health (NIH) image software. Moreover, the number of podoplanin-positive vascular lumen was counted in both groups.

Results: The number of podoplanin-positive vascular lumen was found to be significantly less in the cases with choroidal melanoma than in those with conjunctival melanoma (p=0.004). However, no difference of podoplanin or CD68 expression was found between conjunctival melanoma and choroidal melanoma. Moreover, no discriminative podoplanin or CD68 expression was found between the metastatic and non-metastatic groups.

Conclusions: The findings of this study show that the number of podoplanin-positive lymphatic lumen, but not podoplanin expression, in choroidal melanoma was significantly less than in conjunctival melanoma. This data implicates that the formation of lymphatic lumen in melanoma might depend on the location of the tumor formation.

Keywords: 744 tumors • 554 immunohistochemistry • 453 choroid: neovascularization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×